about
Discontinuation of dual antiplatelet therapy over 12 months after acute coronary syndromes increases risk for adverse events in patients treated with percutaneous coronary intervention: systematic review and meta-analysis.Cardiac remote ischaemic preconditioning reduces periprocedural myocardial infarction for patients undergoing percutaneous coronary interventions: a meta-analysis of randomised clinical trials.Very long-term results comparing a simple versus a complex stenting strategy in the treatment of coronary bifurcation lesions.Thirty-day readmission rates after PCI in a metropolitan center in Europe: incidence and impact on prognosis.Diffuse coronary disease: short- and long-term outcome after percutaneous coronary intervention.Effects of statins on plaque rupture assessed by optical coherence tomography in patients presenting with acute coronary syndromes: insights from the optical coherence tomography (OCT)-FORMIDABLE registry.Culprit plaque characteristics in younger versus older patients with acute coronary syndromes: An optical coherence tomography study from the FORMIDABLE registry.Optical coherence tomography compared with fractional flow reserve guided approach in acute coronary syndromes: A propensity matched analysis.Impact of an optical coherence tomography guided approach in acute coronary syndromes: A propensity matched analysis from the international FORMIDABLE-CARDIOGROUP IV and USZ registry.[Percutaneous treatment of chronic total occlusions: state of the art and future perspectives].Temporal course of vascular healing and neoatherosclerosis after implantation of durable- or biodegradable-polymer drug-eluting stentsPrevalence and outcome of patients with cancer and acute coronary syndrome undergoing percutaneous coronary intervention: a BleeMACS substudyRotational atherectomy with the new RotaPro system over RG3 guidewire in subadventitial retrograde highly calcified CTO PCI
P50
Q38195850-66E97EA0-DCF5-489D-A76B-EE03B3D103C3Q38206342-EAFA2C43-0704-4092-AAB1-37C8AB1DB1CFQ43976063-3B2FA77D-AF6A-4660-BA8E-7F117C1D7DA8Q44047808-7284FEA3-A737-4757-A5CD-94F19994AC71Q45807421-DCE2864E-D0C2-4685-A9D3-2FE9E4341728Q47286408-2248A1CF-43AE-4283-87F8-1CB81148F44BQ47836364-DA409774-CB0A-4D82-9300-AF59DE70FB79Q47858014-F5D64F1B-3C78-43A9-B326-AA9ECAA605A7Q48010369-140AC647-C1D0-4868-922D-4E36CDBFB47BQ53497975-0128D202-604E-4553-B3B0-04D5D0462AD7Q56369731-ACA043AE-F27B-4AD0-9B47-DF7E3AC1A4A0Q88262707-82B156F9-D3BC-44CD-ADBF-D3D89C218A83Q92558970-4B34D447-C2DC-4B43-9C41-70F44C6CB235
P50
description
investigador
@es
researcher
@en
name
Francesco Colombo
@en
type
label
Francesco Colombo
@en
prefLabel
Francesco Colombo
@en
P31
P496
0000-0003-2150-290X